07:08:56 EDT Sat 18 Aug 2018
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:HALO from 2017-08-18 to 2018-08-17 - 41 items
DateSymPriceTypeHeadline
2018-08-07 16:21HALONews ReleaseHalozyme Reports Second Quarter 2018 Results
2018-08-07 15:46HALONews ReleaseHalozyme Therapeutics, Inc. to Host Earnings Call
2018-07-26 16:15HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Healthcare Conference
2018-07-26 08:00HALONews ReleasePhase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE ® Technology
2018-07-11 08:30HALONews ReleaseFDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
2018-07-06 08:00HALONews ReleaseHalozyme To Host Second Quarter 2018 Financial Results Conference Call
2018-06-13 08:00HALONews ReleaseReport: Exploring Fundamental Drivers Behind Virtu Financial, Littelfuse, Gogo, Brookfield Asset Management, Protalix BioTherapeutics, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
2018-06-11 08:30HALONews ReleaseHalozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego
2018-06-01 08:30HALONews ReleaseHalozyme Identifies Plasma Biomarkers As Potential Predictors Of Survival In Pancreatic Cancer
2018-05-29 16:15HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Healthcare Conferences
2018-05-10 16:05HALONews ReleaseHalozyme Reports First Quarter 2018 Results
2018-04-10 08:00HALONews ReleaseHalozyme To Host First Quarter 2018 Financial Results Conference Call
2018-03-22 17:46HALONews ReleaseSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Halozyme Therapeutics, Inc.
2018-03-22 16:05HALONews ReleaseHalozyme Announces Nomination Of Directors For Reelection At 2018 Stockholder Meeting
2018-03-14 16:37HALONews ReleaseHalozyme To Present Data From Six Nonclinical Studies At American Association Of Cancer Research Annual Conference
2018-02-27 08:00HALONews ReleaseHalozyme Therapeutics To Present At Upcoming Healthcare Conference
2018-02-23 07:45HALONews ReleaseNew Research: Key Drivers of Growth for Trinseo S.A, Camden Property Trust, Lions Gate Entertainment, Aramark, J.M. Smucker, and Halozyme Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
2018-02-20 16:05HALONews ReleaseHalozyme Reports Fourth Quarter And Full-Year 2017 Results
2018-02-20 12:04HALONews ReleaseHalozyme Therapeutics, Inc. to Host Earnings Call
2018-01-22 08:00HALONews ReleaseHalozyme To Host Fourth Quarter And Full-Year 2017 Financial Results Conference Call
2018-01-19 14:46HALONews ReleaseGlancy Prongay & Murray LLP Commences Investigation on Behalf of Halozyme Therapeutics, Inc. Investors (HALO)
2018-01-17 14:50HALONews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO)
2018-01-17 13:48HALONews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO
2018-01-09 18:30HALONews ReleaseHalozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018
2017-12-27 08:00HALONews ReleaseHalozyme Therapeutics To Present At The 36th Annual J.P. Morgan Healthcare Conference
2017-12-07 06:30HALONews ReleaseAlexion and Halozyme Enter License Agreement for ENHANZE Technology
2017-12-06 08:00HALONews ReleaseReport: Developing Opportunities within Aramark, J.M. Smucker, Halozyme Therapeutics, Trinseo S.A, Camden Property Trust, and Lions Gate Entertainment — Future Expectations, Projections Moving into 2018
2017-11-15 08:00HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Healthcare Conferences
2017-11-14 14:56HALONews ReleaseCORRECTING and REPLACING – Recent Analysis Shows Pure Storage, Catalent, Boyd Gaming, Halozyme Therapeutics, Clovis Oncology, and General Cable Market Influences – Renewed Outlook, Key Drivers of Growth
2017-11-13 07:50HALONews ReleaseRecent Analysis Shows Pure Storage, Catalent, Boyd Gaming, Halozyme Therapeutics, Clovis Oncology, and General Cable Market Influences – Renewed Outlook, Key Drivers of Growth
2017-11-10 08:30HALONews ReleaseHalozyme To Present Nonclinical Data At SITC 2017 Supporting Combination Of PEGPH20 With Checkpoint Inhibitors
2017-11-07 16:05HALONews ReleaseHalozyme Reports Third Quarter 2017 Results
2017-11-07 10:10HALONews ReleaseHalozyme Therapeutics, Inc. to Host Earnings Call
2017-10-31 08:30HALONews ReleasePhase 3 Study Of Subcutanous Daratumumab Initiated Using Halozyme's ENHANZE Technology
2017-10-24 08:30HALONews ReleaseFirst Gastric Cancer Patient Dosed In Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy
2017-10-16 08:00HALONews ReleaseHalozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients
2017-10-10 08:00HALONews ReleaseHalozyme to Host Third Quarter 2017 Financial Results Conference Call
2017-09-14 07:05HALONews ReleaseHalozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
2017-09-14 07:05HALONews ReleaseHalozyme Increases 2017 Financial Guidance
2017-09-14 06:59HALONews ReleaseBristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology
2017-08-25 08:00HALONews ReleaseHalozyme Therapeutics To Present At Upcoming Healthcare Conferences